Hengkang Medical Group Co Ltd Asset Resilience Ratio

Latest as of June 2025: 0.10%

Hengkang Medical Group Co Ltd asset resilience ratio. Hengkang Medical Group Co Ltd (002219) has an Asset Resilience Ratio of 0.10% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hengkang Medical Group Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥6.50 Million
≈ $950.49K USD Cash + Short-term Investments

Total Assets

CN¥6.73 Billion
≈ $984.39 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Hengkang Medical Group Co Ltd (2015–2024)

Asset resilience ratio of Hengkang Medical Group Co Ltd from 2015 to 2024. This chart shows how Hengkang Medical Group Co Ltd's Asset Resilience Ratio has changed over time. Read debt load of Hengkang Medical Group Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Hengkang Medical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Hengkang Medical Group Co Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥6.50 Million 0.1%
Total Liquid Assets CN¥6.50 Million 0.10%

Asset Resilience Insights

  • Limited Liquidity: Hengkang Medical Group Co Ltd maintains only 0.10% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Hengkang Medical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Hengkang Medical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
IHH Healthcare Bhd
KLSE:5225
Medical Care Facilities 1.23%
Aier Eye Hospital Group
SHE:300015
Medical Care Facilities 3.20%
Ramsay Health Care Ltd
AU:RHC
Medical Care Facilities 3.49%
Vibhavadi Medical Center Public Company Limited
BK:VIBHA
Medical Care Facilities 4.19%
Bait Bakfar Ltd
TA:BKFR
Medical Care Facilities 8.67%
Medical Facilities Corporation
TO:DR
Medical Care Facilities 15.97%
DreamCIS Inc
KQ:223250
Medical Care Facilities 5.51%
P3 Health Partners Inc
NASDAQ:PIII
Medical Care Facilities 402.86%

Hengkang Medical Group Co Ltd Asset Resilience Ratio by Year (2015–2024)

Hengkang Medical Group Co Ltd asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for Hengkang Medical Group Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.10% CN¥6.56 Million
≈ $959.95K
CN¥6.68 Billion
≈ $977.08 Million
+0.10pp
2017-12-31 0.00% CN¥50.00K
≈ $7.32K
CN¥10.25 Billion
≈ $1.50 Billion
0.00pp
2016-12-31 0.00% CN¥100.00K
≈ $14.63K
CN¥5.98 Billion
≈ $875.75 Million
-1.67pp
2015-12-31 1.67% CN¥80.00 Million
≈ $11.71 Million
CN¥4.78 Billion
≈ $699.52 Million
--
pp = percentage points

About Hengkang Medical Group Co Ltd

SHE:002219 China Medical Care Facilities
Market Cap
$966.58 Million
CN¥6.61 Billion CNY
Market Cap Rank
#8762 Global
#2047 in China
Share Price
CN¥1.95
Change (1 day)
+0.52%
52-Week Range
CN¥1.73 - CN¥2.75
All Time High
CN¥14.23
About

New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiw… Read more